Trial Profile
Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Axitinib (Primary)
- Indications Solid tumours
- Focus Pharmacodynamics; Therapeutic Use
- 11 Dec 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov.
- 11 Dec 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov.
- 24 Sep 2014 Planned End Date changed from 1 Aug 2012 to 1 Dec 2014, as per ClinicalTrials.gov record.